The Radiological Society of North America (RSNA) is hosting its 97th Scientific Assembly & Annual Meeting, Nov. 27 to Dec.2, at McCormick Place in Chicago. The society anticipates nearly 60,000 attendees will head to the Windy City and has arranged a slate of more than 2,400 scientific presentations and posters and 1,800 education exhibits and informatics demonstrations.
This year's RSNA theme—Celebrate the Image—recognizes the tremendous progress and contributions that radiology has made in the last four decades. It also showcases radiologists as leaders and central to the clinical process.
A sampling of top sessions chosen by the Health Imaging editorial staff follows. For additional previews, please visit HealthImaging.com and be sure to check in for our live conference coverage from Nov. 27 to Dec. 1.
Saving Our Profession: How Radiologists Can Thrive in the Era of Healthcare Reform
Sunday, Nov. 27, 2:00-3:30 | S503AB
With policymakers scrutinizing imaging and competition continuing to escalate, independent imaging practices face the risk of extinction. A trio of experts presents and assesses the challenge and possible solutions.
- Bruce J. Hillman, MD, professor of radiology, University of Virginia, Charlottesville
- Lawrence R. Muroff, MD, CEO and president, Imaging Consultants, Tampa, Fla.
- Jeff Goldsmith, PhD, president, Health Futures, Charlottesville, Va.
Shaping Your Future Practice: ACOs and Practice Development
Sunday, Nov. 27, 5:00-06:00 | S402AB
Designed to help attendees understand the concept of the accountable care organization (ACO), this session addresses the delivery model and how it will influence the practice of medical imaging.Speakers also explore licensure, reimbursement and position responsibilities of the radiologist assistant.
- Claudia A. Murray, principal and CEO, CMC Consulting, Fallston, Md.
- Joy J. Renner MA, RT, division director, University of North Carolina Health Care System, Chapel Hill
Meaningful Use: Experience from Radiology Practices
Tuesday, Nov. 29, 12:30-2:00 | S501ABC
Several practices with rich meaningful use experience share their approaches, discuss challenges and provide strategies to participate in the meaningful use process with the hospital or multi-specialty practice.
- James T. Whitfill, MD, CIO, Scottsdale Medical Imaging, Ariz.
- David L. Weiss, MD, physician coordinator for imaging informatics, Carilion Clinic, Roanoke, Va.
- J. Raymond Geis, MD, Advanced Medical Imaging Consultants, Fort Collins, Colo.
- Steven F. Fischer, CIO, Center for Diagnostic Imaging, Minneapolis
- Alberto Goldszal, PhD, MBA, CIO, University Radiology Group, New Brunswick, N.J.
Brain Imaging Work-up for Dementia: FDG-PET, Amyloid PET and MR Imaging
Sunday, Nov. 27, 2:00-3:30 | E451A
Designed for physicians and researchers involved in brain PET imaging of dementia, this refresher course explores the role of various modalities in the diagnosis and work-up of dementia. Speakers also will discuss new radiotracers for amyloid imaging.
- Satoshi Minoshima, MD, PhD, professor and vice chair of radiology research, University of Washington, Seattle
- Yoshimi Anzai, MD, director of neuroradiology, University of Washington, Seattle
- Alexander Drzezga, MD, department of nuclear medicine, TU Meunchen, Munich
- Kirk A. Frey, MD, PhD, division of nuclear medicine, University of Michigan Hospitals, Ann Arbor
Essentials of Molecular Imaging and Systems Diagnostics for Clinical Radiologists
Sunday, Nov. 27, 2:00-3:30 | E352
This course presents the basics of molecular imaging, reviews molecular imaging probes and explores theranostics as well as future directions in molecular imaging. It addresses systems diagnostics, bioinformatics and quantitative medical imaging.
- Martin Gilbert Pomper, MD, PhD, neuroradiologist, John Hopkins University, Baltimore
- King C. Li, MD, director of department of translational imaging, Methodist Hospital Research Institute, Houston
Molecular Oncology Meets Molecular Imaging: How Can We Prepare for the Future?
Wednesday, Nov. 30, 10:30-12:00 | S406B
This session dives into the future of molecular oncology, introducing attendees to an array of topics, including: molecular targets and personalized treatments, with a focus on non-small-cell lung cancer; novel PET tracers; the role of CT and MRI and radiogenomics.